This framework agreement aims to establish subsequent contracts for the procurement of medicines for the treatment of individuals with HIV/AIDS and for post-exposure treatment (2024-2025). The specific medications include BICTEGRAVIR, EMTRICITABINE, and TENOFOVIR in dosages of 50 mg/200 mg/25 mg, as
Contract awarded. Originally published 11 months ago.
Mostly framework call-offs rather than head-to-head competition.
In healthcare medical, PETROSANI EMERGENCY HOSPITAL has awarded 2 contracts to 2 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves establishing subsequent contracts for the procurement of specialized road transport services for dialysis patients from 2026 to 2029. The specific details and quantities of the services required are outlined in the specifications document. Suppliers have 18 days to request cla
This framework agreement aims to establish subsequent contracts for the procurement of dialysis supplies for the period 2026-2029, as detailed in the specifications document. Suppliers have 18 days to request clarifications before the deadline for submitting offers. The contracting authority will pr
This contract involves establishing a framework agreement for the procurement of antiseptics and disinfectants for the years 2025 to 2028. Suppliers will be required to provide these products in accordance with the specifications and quantities outlined in the tender documents. Suppliers have 18 day
UK Home Office seeks a global tuberculosis screening service provider to manage visa applicant testing across international locations through various delivery models.
Norfolk County Council is seeking a contractor to provide technology-enabled and virtual care services that help residents maintain independence and improve outcomes while remaining in their own homes.
Market engagement RFI for integrated criminal justice liaison, prison reentry and mental health treatment services across Lancashire and Cumbria, closing 4 September 2026.
UKHSA is seeking supplier participation in a market engagement exercise for Pralidoxime Chloride supply in 2026 through a formal Request for Information process.
